Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucagon-like peptide 1-baseret behandling af type 2-diabetes mellitus

Research output: Contribution to journalReviewResearchpeer-review

  1. Balanced translocation in a patient with abortus habitualis and normal karyotype

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The effect of antidepressants on brain volume

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Nyt studie viser, at motion beskytter mod depression

    Research output: Contribution to journalContribution to newspaper - Comment/debateCommunication

  4. Gentagne diploid biparental molae

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Lukning af forreste tredjedel af sinus sagittalis superior hos en patient med to blyanter i hjernen

    Research output: Contribution to journalJournal articleCommunication

  1. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prognostic value of ratio of transmitral early filling velocity to early diastolic strain rate in patients with Type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Liver-α-Cell Axis and Type 2 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  4. Evaluation of clinical translatability of the diet-induced obese and biopsy-confirmed gubra amylin mouse model of non-alcoholic steatohepatitis

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Gluco-metabolic effects of oral and intravenous alcohol administration in men

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
GLP-1 is secreted from the small intestine in response to ingestion of nutrients. It has a powerful insulinotropic effect and stimulates beta-cell growth and is therefore being developed for treatment of type 2 diabetes. The GLP-1 analogue, exenatide, is on the market in the USA as an add-on therapy. Another strategy to increase circulating GLP-1 is to inhibit the enzyme DPP-IV which degrades endogenous GLP-1. GLP-1-based therapy results in HbA1c reductions of approximately 1 percent point, and the lack of serious side effects and the low risk of hypoglycaemic episodes are unique traits.
Translated title of the contribution[GLP-1-based treatment of type 2 diabetes mellitus]
Original languageDanish
JournalUgeskrift for Laeger
Volume169
Issue number22
Pages (from-to)2095-9
Number of pages5
Publication statusPublished - 28 May 2007

ID: 32267871